Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jun 15;99(12):2814–2816. doi: 10.1172/JCI119472

Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis.

S M Schwartz 1
PMCID: PMC508129  PMID: 9185501

Full Text

The Full Text of this article is available as a PDF (782.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendeck M. P., Irvin C., Reidy M. A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res. 1996 Jan;78(1):38–43. doi: 10.1161/01.res.78.1.38. [DOI] [PubMed] [Google Scholar]
  2. Boström H., Willetts K., Pekny M., Levéen P., Lindahl P., Hedstrand H., Pekna M., Hellström M., Gebre-Medhin S., Schalling M. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996 Jun 14;85(6):863–873. doi: 10.1016/s0092-8674(00)81270-2. [DOI] [PubMed] [Google Scholar]
  3. Choi E. T., Engel L., Callow A. D., Sun S., Trachtenberg J., Santoro S., Ryan U. S. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994 Jan;19(1):125–134. doi: 10.1016/s0741-5214(94)70127-x. [DOI] [PubMed] [Google Scholar]
  4. Clarkson T. B., Prichard R. W., Morgan T. M., Petrick G. S., Klein K. P. Remodeling of coronary arteries in human and nonhuman primates. JAMA. 1994 Jan 26;271(4):289–294. [PubMed] [Google Scholar]
  5. Clyman R. I., Goetzman B. W., Chen Y. Q., Mauray F., Kramer R. H., Pytela R., Schnapp L. M. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: an immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus. Pediatr Res. 1996 Aug;40(2):198–208. doi: 10.1203/00006450-199608000-00004. [DOI] [PubMed] [Google Scholar]
  6. DeRuiter M. C., Poelmann R. E., VanMunsteren J. C., Mironov V., Markwald R. R., Gittenberger-de Groot A. C. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 1997 Apr;80(4):444–451. doi: 10.1161/01.res.80.4.444. [DOI] [PubMed] [Google Scholar]
  7. Gotwals P. J., Chi-Rosso G., Lindner V., Yang J., Ling L., Fawell S. E., Koteliansky V. E. The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest. 1996 Jun 1;97(11):2469–2477. doi: 10.1172/JCI118693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoshiga M., Alpers C. E., Smith L. L., Giachelli C. M., Schwartz S. M. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res. 1995 Dec;77(6):1129–1135. doi: 10.1161/01.res.77.6.1129. [DOI] [PubMed] [Google Scholar]
  9. Jain M., He Q., Lee W. S., Kashiki S., Foster L. C., Tsai J. C., Lee M. E., Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1996 Feb 1;97(3):596–603. doi: 10.1172/JCI118455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Li J., Sensebé L., Hervé P., Charbord P. Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway. Exp Hematol. 1995 Feb;23(2):133–141. [PubMed] [Google Scholar]
  11. Liaw L., Lombardi D. M., Almeida M. M., Schwartz S. M., deBlois D., Giachelli C. M. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):188–193. doi: 10.1161/01.atv.17.1.188. [DOI] [PubMed] [Google Scholar]
  12. Lowery M. C., Morris C. A., Ewart A., Brothman L. J., Zhu X. L., Leonard C. O., Carey J. C., Keating M., Brothman A. R. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am J Hum Genet. 1995 Jul;57(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  13. Majesky M. W., Schwartz S. M. An origin for smooth muscle cells from endothelium? Circ Res. 1997 Apr;80(4):601–603. [PubMed] [Google Scholar]
  14. Matsuno H., Stassen J. M., Vermylen J., Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994 Nov;90(5):2203–2206. doi: 10.1161/01.cir.90.5.2203. [DOI] [PubMed] [Google Scholar]
  15. Mogford J. E., Davis G. E., Platts S. H., Meininger G. A. Vascular smooth muscle alpha v beta 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res. 1996 Oct;79(4):821–826. doi: 10.1161/01.res.79.4.821. [DOI] [PubMed] [Google Scholar]
  16. Schwartz S. M., deBlois D., O'Brien E. R. The intima. Soil for atherosclerosis and restenosis. Circ Res. 1995 Sep;77(3):445–465. doi: 10.1161/01.res.77.3.445. [DOI] [PubMed] [Google Scholar]
  17. Svee K., White J., Vaillant P., Jessurun J., Roongta U., Krumwiede M., Johnson D., Henke C. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest. 1996 Oct 15;98(8):1713–1727. doi: 10.1172/JCI118970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thayer J. M., Giachelli C. M., Mirkes P. E., Schwartz S. M. Expression of osteopontin in the head process late in gastrulation in the rat. J Exp Zool. 1995 Jun 15;272(3):240–244. doi: 10.1002/jez.1402720309. [DOI] [PubMed] [Google Scholar]
  19. Weber G. F., Ashkar S., Glimcher M. J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 1996 Jan 26;271(5248):509–512. doi: 10.1126/science.271.5248.509. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES